Complete Androgen blockade in Advanced Prostate Cancer: A clinical experience
Article Sidebar
Main Article Content
Abstract
To evaluate the clinical and biochemical outcome of patients with advanced prostate cancer treated by complete androgen blockage (CAB). A total number of 30 patients with histologically confirmed advance prostate cancer and seru8m PSA level of more than 30ng/ml were subjected to bilateral subcapsular orchidectomy. Supplemented with oral anti androgens. These patients were followed for a period of two years by recording their symptoms and serum PSA level at twelve weeks intervals. CAB is still the treatment of choice for patients with advanced prostate cancer.
Article Details
How to Cite
1.
Haq A ul, Ghani A, Khan TA, Khan I. Complete Androgen blockade in Advanced Prostate Cancer: A clinical experience. J Postgrad Med Inst [Internet]. 2011 Oct. 6 [cited 2024 Dec. 22];18(4). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/1191
Issue
Section
Original Article
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.